A detailed history of Teacher Retirement System Of Texas transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Teacher Retirement System Of Texas holds 14,878 shares of CLDX stock, worth $364,362. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,878
Previous 12,733 16.85%
Holding current value
$364,362
Previous $471,000 7.22%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$32.06 - $44.56 $68,768 - $95,581
2,145 Added 16.85%
14,878 $505,000
Q2 2024

Aug 09, 2024

BUY
$32.76 - $42.56 $1,736 - $2,255
53 Added 0.42%
12,733 $471,000
Q1 2024

May 06, 2024

BUY
$35.22 - $51.88 $46,631 - $68,689
1,324 Added 11.66%
12,680 $532,000
Q4 2023

Feb 07, 2024

SELL
$22.61 - $40.65 $994 - $1,788
-44 Reduced 0.39%
11,356 $450,000
Q3 2023

Oct 31, 2023

BUY
$25.45 - $37.46 $13,284 - $19,554
522 Added 4.8%
11,400 $314,000
Q2 2023

Jul 19, 2023

SELL
$30.29 - $38.28 $22,111 - $27,944
-730 Reduced 6.29%
10,878 $369,000
Q1 2023

May 12, 2023

BUY
$34.78 - $47.43 $15,129 - $20,632
435 Added 3.89%
11,608 $418,000
Q4 2022

Feb 10, 2023

SELL
$27.78 - $45.38 $31,196 - $50,961
-1,123 Reduced 9.13%
11,173 $498,000
Q3 2022

Nov 03, 2022

BUY
$22.7 - $37.57 $279,119 - $461,960
12,296 New
12,296 $346,000
Q2 2022

Aug 09, 2022

SELL
$20.5 - $37.33 $158,772 - $289,120
-7,745 Closed
0 $0
Q1 2022

May 09, 2022

BUY
$27.64 - $39.32 $16,418 - $23,356
594 Added 8.31%
7,745 $264,000
Q4 2021

Feb 10, 2022

BUY
$35.68 - $56.27 $36,357 - $57,339
1,019 Added 16.62%
7,151 $276,000
Q3 2021

Nov 09, 2021

BUY
$28.95 - $55.99 $177,521 - $343,330
6,132 New
6,132 $331,000

Others Institutions Holding CLDX

About Celldex Therapeutics, Inc.


  • Ticker CLDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,772,400
  • Market Cap $1.15B
  • Description
  • Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...
More about CLDX
Track This Portfolio

Track Teacher Retirement System Of Texas Portfolio

Follow Teacher Retirement System Of Texas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

News

Stay updated on Teacher Retirement System Of Texas with notifications on news.